Legal status · United States
Is Sodium phenylbutyrate legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Sodium phenylbutyrate is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile.
Sodium phenylbutyrate in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Approved for urea cycle disorders. A combination product containing it was approved for ALS and later withdrawn after the confirmatory phase 3 did not succeed. No ageing indication. |
| FDA approval status | FDA-approved for urea cycle disorders. Also formed part of a combination product approved for amyotrophic lateral sclerosis that was subsequently withdrawn after its confirmatory trial failed. No ageing indication. |
| Human studies cited | 0 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Sodium phenylbutyrate profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Sodium phenylbutyrate for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Sodium phenylbutyrate is
A chemical chaperone that relieves endoplasmic reticulum stress, and a weak HDAC inhibitor, so it targeted two ageing mechanisms at once. It did not extend mouse lifespan in either sex.
This compound was an attractive candidate because it hits two things on the standard list of ageing hallmarks. Loss of proteostasis is one, and 4-phenylbutyrate is a chemical chaperone that helps misfolded proteins fold and relieves endoplasmic reticulum stress.
Mechanism: Two established activities. As a chemical chaperone it stabilises protein folding intermediates non-specifically and reduces the unfolded protein response, which is the basis of its use in conditions of protein misfolding.
Regulatory history: FDA-approved for urea cycle disorders. Also formed part of a combination product approved for amyotrophic lateral sclerosis that was subsequently withdrawn after its confirmatory trial failed. No ageing indication.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Sodium phenylbutyrate at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Sodium phenylbutyrate in other countries
United Kingdom
ApprovedLicensed, prescription only (MHRA)
Is Sodium phenylbutyrate legal in the United Kingdom?Australia
ApprovedTGA-registered, prescription only
Is Sodium phenylbutyrate legal in Australia?Canada
ApprovedHealth Canada approved, prescription only
Is Sodium phenylbutyrate legal in Canada?Frequently asked questions
Is Sodium phenylbutyrate legal in the United States?
Yes. Sodium phenylbutyrate is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile. Note: Approved for urea cycle disorders. A combination product containing it was approved for ALS and later withdrawn after the confirmatory phase 3 did not succeed. No ageing indication.
Can I buy Sodium phenylbutyrate in the United States?
Only with a prescription. Sodium phenylbutyrate is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Approved for urea cycle disorders. A combination product containing it was approved for ALS and later withdrawn after the confirmatory phase 3 did not succeed. No ageing indication.
Is Sodium phenylbutyrate FDA approved?
Yes. FDA status: FDA-approved for urea cycle disorders. Also formed part of a combination product approved for amyotrophic lateral sclerosis that was subsequently withdrawn after its confirmatory trial failed. No ageing indication.. Current US classification: "FDA-approved, prescription only". On the evidence, no human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Sodium phenylbutyrate live on its compound profile.
Sodium phenylbutyrate profileThis page is general information about the regulatory status of Sodium phenylbutyrate in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.